OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-03-31-accounts

2021 2020
Unrestricted Restricted Total Total
fund funds funds funds
Notes F
INCOME AND ENDOWMENTS FROM
Donations
and legacies
3 1,726,274 1,726,274 1,053,057
Other trading
activities
4 324,408 324,408 1,027,062
Investment
income
5 104,967 104,967 114,321
Other income 6 59,362 59,362 20,701
Total 2,215,011 2,215,011 2,215,141
EXPENDITURE ON
Raising funds 583,814 583,814 862,505
Charitable
activities
Research projects 883,695 8,397 892092 2 544 440
Total 1,467,509 8,397 1,475,906 3,406,945
Net gains/(losses)
on
investments 756,570 756.570 ~155,705)
NET INCOME/(EXPENDITURE) 1,504,072 (8,397) 1,495,675 (1,347,509)
RECONCILIATION
OF FUNDS
Total funds brought forward 3,455,034 365,408 3,820,442 5,167,951
TOTAL FUNDS CARRIED FORWARD 4,959,106 357,011 5,316,117 3,820,442

2021
Urfrestricted Restrfrsted Total Tefal
fUnd iUnci 5 IUIICo fUI
'.ras
C k 6
FlXED ASSETS
li rtai19fbtLa assetS
Tal"I&I".bfe issets
ff1VLasf irrerfte
trrf
17
I or
«,889
2='i,!82
*.301..:65
4,889
25,782
!,80i,865
9 !8eJ
29 !35-1
3.I88, 05
4,832,536 4,8 r2,53!& ",' 'L'I.-, U18
CURRENT ASSETS
Qebtors
Cash ai barite arid
i'.1 "Brief
:9 7 '.9,258
2,807,760
365a408 749
r58
3,1 s3.168
508, 774
3 f24,957
3557,018 365.-'08 3,922.426: .533731
CREDITORS
Ai'IIC'irrtftS
ialllflti 6'I . VSil)iln «iii
)refdr 20 i;620428t i8 3$71 i'628,825; f396,34"i;
NET CUPPENT ASSETS ;?,936,590 357,0t 1 3, .9i,601 3il37,390
TOT~P
ASSETS
LESSCURRENT UABiLITfES i',769,126 35,0 1 8.t26it37 7,184,038
PRGVfSIONS FOR LfABILfTfES 22 !2,8 f0,020) (2,810,020 i (3,34':.598(
l,959,":0I6 37ti"1 ~ !6i 7 3 II2s0,442
Unre
Iri-ted!!Inde
4,95Cs,106 ~,»5-,0s4
Lostnctedi
',Uirds
TOTALFUNDS 5.316,117 "-',820,442

2021 2020
Notes E F
Cash flows from operating activities
Cash generated
from operations
104,805 238,121
Interest paid 5
Net cash provided
by operating
activities
104,805 238,126
Cash flows from investing activities
Purchase of intangible
fixed assets
Purchase oftangible
fixed assets
(4,670) (11,935)
(14,340)
Purchase offixed asset investments
Sale of intangible
fixed assets
Sale oftangible
fixed assets
(1,064,361) (1,263,532)
(30,530)
38,530
Sale offixed asset investments 1,007,471 1,169,718
Interest received 18,064 19,363
Dividends
received
86,902 94,958
Net cash (used in)/provided by investing activities 43,406 2,232
Change
in cash and cash
equivalents in
the reporting
period
148,211 240,358
Cash and cash equivalents at the
beginning
ofthe reporting
period 3,024,957 2,784,599
Cash and cash equivalents at the end of
the reporting
period
3,173,168 3,024,957

ACTIVITIES
2021 2020
F f
Net income/(expenditure) for the reporting period (as per the
Statement of Financial Activities)
Adjustments
for:
1,495,675 (1,347,509)
Depreciation
charges
12,242 15,044
(Gain)/losses
on investments
(786,038) 202,311
Loss on disposal of fixed assets 30,546
Interest received (18,064) (19,363)
Interest paid
Dividends
received
(86,902) (5)
(94,958)
Discounting
of provisions
29,468 (18,720)
Dilapidations
provision
150,996
Decrease
in stocks
1,120
(Increase)/decrease in debtors (240,484) 487,321
(Decrease)/increase in creditors ~3O1,092 831,338
Net cash provided by operations 104,805 238,121
ANALYSIS OF CHANGES IN NET FUNDS
At 1/4/20
F
Cash flow
f
At 31/3/21
F
Net cash
Cash at bank and in hand 3,024,957 148,211 3,173,168
3,024,957 148,211 3,173,168
Total 3,024,957 148,211 3,173,168

OTHER INCOME
2021 2020
F
Discounting
of provisions
(29,468) 18,720
Insurance
claim
85,830
Miscellaneous
income
3,000 1,981
59,362 20,701
RAISING FUNDS
Raising donations and legacies
2021 2020f
Fundraising
staff costs
211,940 192,040
Gift aid and legacy expenses 3,513 6,710
Events and general fundraising expenditure 11,002 68,819
Advertising
and publicity
928 9,836
Other fundraising
expenses
6,180 24,638
Depreciation 412 476
233,975 302,519
Other trading activities
2021 2020
Retail staff costs 151,434 169,299
Retail purchases 920 7,038
Retail and warehouse premises costs 131,348 143,109
Other retail costs 24,301 44,849
Merchandise
purchases
including Christmas cards 3,985 4,814
Dilapidations 150,996
Depreciation 7,255 9,718
Loss on sale ofassets 16
319,243 529,839

RAISING FUNDS - continued RAISING FUNDS - continued RAISING FUNDS - continued RAISING FUNDS - continued RAISING FUNDS - continued
Investment management costs
2021 2020
F
Investment management costs 30,596 30,147
Aggregate amounts 583,814 862,505
CHARITABLE ACTIVITIES COSTS
Grant
funding of
Direct activities Support
Costs (see (see note costs (see
note 9) 10) note 11) Totals
F F F
Research projects 126,302 456,287 309,503 892,092
DIRECT COSTS OF CHARITABLE ACTIVITIES
2021 2020
F F
Staff costs 96,568 86,886
Direct cancer research expenditure 20,740 (3,811)
Science communication costs 8,719 320
Depreciation 275 317
126,302 83,712
GRANTS PAYABLE
2021 2020
F F
Research projects 456,287 2,117,505
The total grants
paid to
institutions during the year was as follows:
2021 2020
F
Velindre
NHS Trust
147,731 79,341
Cardiff University 266,132 1,571,045
Bangor University
Other adjustments
on project closures 47,000
~4,576)
481,322
~14,203)
456,287 2,117,505

STAFF COS TS
2021 2020
f. f
Wages and salaries 575,617 553,227
Redundancy costs 23,855
Social security costs 52,819 46,787
Pension 50,760 46,141
703,051 646,155
The average monthly number ofemployees during the year was as follows:
2021 2020
Fundraising 6 6
Retail 7 7
Administration/ Governance 6 7
19 20
The number ofemployees whose emoluments amounted toa rate ofover F60,000 during the year were as follow
2021 2020
No. No.
F60,001 - F70,000 1
Pension contributions 9,100

Unrestricted Restricted Total
fund funds funds
F
INCOME AND ENDOWMENTS FROM
Donations
and legacies
1,053,057 1,053,057
Other trading
activities
981,074 45,988 1,027,062
Investment
income
114,321 114,321
Other income 20,701 20,701
Total 2,169,153 45,988 2,215,141
EXPENDITURE ON
Raising funds 862,505 862,505
Charitable
activities
Research projects 2,544,440 2,544,440
Total 3,406,945 3,406,945
Net gains/(losses)
on
investments ~155,705) ~155,705)
NET INCOME/(EXPENDITURE) (1,393,497) 45,988 (1,347,509)
RECONCILIATION
OF FUNDS
Total funds brought forward 4,848,531 319,420 5,167,951
TOTAL FUNDS CARRIED FORWARD 3,455,034 365,408 3,820,442

2021 2020
Financial assets F F
Financial assets that are debt instruments measured at amortised cost 3,898,333 3,502,762
Financial assets measured at fair value 4,689,108 3,988,405
2021 2020
Financial liabilities
Financial liabilities measured at amortised cost 475,288 396,341
Financial liabilities measured at fair value 2,810,020 3,343,596

INTANGIBLE FIXEDASSETS
Computer
software
P
COST
At 1 April 2020 and 31 March 2021 14,922
AMORTISATION
At 1 April 2020 5,733
Charge for year 4,300
At 31 March 2021 10,033
NET BOOK VALUE
At 31 March 2021 4,889
At 31 March 2020 9,189

TANGIBLE FIXEDASSETS
Leasehold
property Fixtures Motor
improvements 8 Equipment vehicles Totals
COST
At 1 April 2020 103,101 37,897 20,216 161,214
Additions 4,670 4,670
At 31 March 2021 107,771 37,897 20,216 165,884
DEPRECIATION
At 1 April 2020 96,971 18,342 16,847 132,160
Charge for year 3,027 3,611 1,304 7,942
At 31 March 2021 99,998 21,953 18,151 140,102
NET BOOK VALUE
At 31 March 2021 7,773 15,944 2,065 25,782
At 31 March 2020 6,130 19,555 3,369 29,054
18. FIXEDASSET INVESTMENTS FIXEDASSET INVESTMENTS FIXEDASSET INVESTMENTS FIXEDASSET INVESTMENTS
Investments
MARKET VALUE
At 1 April 2020 3,988,405
Additions 1,064,361
Disposals (1,007,471)
Revaluations 756,570
At 31 March 2021 4,801,865
NET BOOK VALUE
At 31 March 2021 4,801,865
At 31 March 2020 3,988,405
2021 2020
F
Historical cost of investments 3,586,443 3,588,929
Analysis ofinvestments between funds:
2021 2020
Listed investments 4,780,526 3,988,405
UK cash held as part of portfolio 21,339
4,801,865 3,988,405
Cost or valuation at 31 March 2021 is represented by:
Investments
f
Valuation in 2020 458,852
Valuation in 2021 756,570
Cost 3,586,443
4,801,865
19. DEBTORS:AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
F
Other debtors 71,540
Legacies
VAT
due 569,725 477,805
5,793
Prepayments
and
accrued income 107,993 25,176
749,258 508,774

CREDITORS: AMOUN TS FALLING DUE WITHIN ONE Y EAR
2021 2020
E
VAT payable 5,918
Social security and other taxes 13,223
Project funding payments due 279,081 351,947
Other creditors 150,346 32,486
Accruals and deferred income 180,257 11,908
628,825 396,341

Minimum
lease payments
under non-cancellable
operating
leases fall due as follows:
2021 2020
Z
Within one year 59,000 62,115
Between one and five years 26,625 84,625
85,625 146,740

2021 2020
Project grant commitments 2,659,024 3,192,600
Dilapidations
provision
150,996 150,996
2,810,020 3,343,596
Project grant
commitments
F
Balance at 1 April 2020 3,192,600
New project grant commitments 460,866
Grants payable
in
the year (1,019,332)
Grant underspend written back (4,578)
Discounting
ofprovisions
29,468
Balance at 31 March 2021 2,659,024

23. MOVEMENT MOVEMENT IN FUNDS IN FUNDS
Net
movement At
At 1/4/20 in funds 31/3/21
F
Unrestricted funds
General
fund
3,455,034 1,504,072 4,959,106
Restricted funds
Brain Tumour Scholarship 150,000 150,000
Bowel Cancer Research Fund 61,920 61,920
Tom Walker Fund - Acute Myeloid
Leukaemia 145,988 (8,397) 137,591
Millennium Stadium Charitable Trust 7,500 7,500
365,408 8,397 357,011
TOTAL FUNDS 3,820,442 1,495,675 5,316,117
Net movement in funds, included in the above are as follows:
Incoming Resources Gains and Movement
resources
f
expended
F
losses in funds
Unrestricted funds
General
fund
2,215,011 (1,467,509) 756,570 1,504,072
Restricted funds
Tom Walker Fund - Acute Myeloid
Leukaemia (8,397) (8,397)
TOTAL FUNDS 2,215,011 ~1,475,906) 756,57D 1,495,675

Comparativ es for move ment in funds
Net
movement At
At 1/4/19 in funds 31/3/20
F F
Unrestricted funds
General
fund
4,848,531 (1,393,497) 3,455,034
Restricted funds
Brain Tumour Scholarship 150,000 150,000
Bowel Cancer Research Fund 61,920 61,920
Tom Walker Fund - Acute Myeloid
Leukaemia 100,000 45,988 145,988
Millennium Stadium Charitable Trust 7,500 7,500
319,420 45,988 365,408
TOTAL FUNDS 5,167,951 ~1,347,509) 3,820,442